학술논문

Treatment-related adverse events as predictive biomarkers of efficacy in patients with advanced neuroendocrine tumors treated with surufatinib: results from two phase III studies

Document Type

Article

Author

Li, J.; Cheng, Y.; Bai, C.; Xu, J.; Shen, L.; Zhou, Z.; Li, Z.; Chi, Y.; Yu, X.; Li, E.; Xu, N.; Liu, T.; Lou, W.; Bai, Y.; Yuan, X.; Wang, X.; Yuan, Y.; Chen, J.; Guan, S.; Fan, S.; Su, W.

Source

In ESMO Open April 2022 7(2)

Subject

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송